A drug commonly prescribed to treat Gout is showing promise in the prevention of colon cancer. Researchers say the drug Allopurinol lowered the risk of colorectal cancer by two-thirds in nearly 1,800 patients who took the drug for five years.
Allopurinol helps patients with Gout by blocking a key enzyme that causes the disease. Researchers believe the drug may also block a process that damages DNA and can lead to cancer.
The study was presented on Monday in Seattle at a meeting of the American Association for Cancer Research.